PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...
PTC Therapeutics (PTCT) announced that the FDA accelerated approval of its gene therapy for the treatment of AADC deficiency, the first-ever ...
A piecemeal treatment approach is to be expected while research progresses, and perhaps longer-term, said Anita Jain, a long ...
More than 800 million adults have diabetes worldwide – almost twice as many as previous estimates have suggested – and more than half of those aged over 30 who have the condition are not receiving ...
When active filaments are exposed to localized illumination, they accumulate into stable structures along the boundaries of ...
Punjab Finance Minister Harpal Singh Cheema emphasises cooperative federalism and structural reforms to achieve Indias ...
Q3 marks the largest bookings in Ondas' history$14.4 million in purchase orders were from a major military customer for the Iron Drone Raider and Optimus System autonomous drone platformsIron Drone Ra ...
LONDON, GREATER LONDON, UNITED KINGDOM, November 12, 2024 /EINPresswire / -- The Business Research Company 's Early Year-End Sale! Get up to 30% off detailed market research reports-limited time only!
Read updates from clinical trials and scientific research on Huntington’s disease from Day 1 of the 2024 Huntington Study ...
Speakers from the Philippines include Migrant Workers Secretary Hans Leo Cacdac, Maritime Industry Authority (Marina) Administrator Sonia Malaluan, PTC Group President and ... They include ...
PTC Therapeutics ( (PTCT) ) has released its Q3 earnings. Here is a breakdown of the information PTC Therapeutics presented to its investors.